Health

EDMONTON — Alberta is planning to dismantle its provincewide health provider and may sell off its publicly owned continuing-care facilities, say leaked cabinet briefing documents released by the Opposition NDP.

EDMONTON — An Alberta government report that influenced safe drug consumption policy is so badly flawed it's harming people and should be withdrawn, says a new study in a prominent medical journal.

NEW ORLEANS (AP) — The Biden administration asked a federal appeals court Tuesday to uphold health care guidance issued in 2022 that says hospitals must provide abortions for women whose lives are at risk due to pregnancy.

More than 40% of American adults are considered obese, yet the medications many take are rarely tested in bigger bodies. That's because they are not required to be included in drug studies. And often, they're explicitly excluded.

BERLIN (AP) — A German federal court on Tuesday denied two seriously ill men direct access to a lethal dose of a drug, arguing that the country's narcotics law stands in the way and that they could turn to assisted suicide to end their lives.

OTTAWA — As the deadline to repay pandemic loans and receive partial forgiveness approaches, small businesses are still hoping the federal government will reverse course and extend it for another year.

NEW DELHI (AP) — A toxic blanket of grey smog hangs over New Delhi’s monuments and high-rises. Schools have been ordered shut and construction banned . People are back to wearing masks. In the Indian capital, it is that time of the year again.

ROME (AP) — An 8-month-old terminally ill British girl was granted Italian citizenship Monday after a court in Britain upheld rulings authorizing the withdrawal of life-supporting invasive treatment.

WASHINGTON (AP) — As U.S. doctors scale back their use of opioid painkillers , a new option for hard-to-treat pain is taking root: ketamine, the decades-old surgical drug that is now a trendy psychedelic therapy .

SAN JUAN, Puerto Rico (AP) — One of Puerto Rico’s biggest distributors of pharmaceutical drugs was ordered to pay $12 million after being accused of not reporting hundreds of suspicious orders for controlled substances, the U.S.